Rituximab in Neuromyelitis Optica Spectrum Disorders: Our Experience

BACKGROUND: Neuromyelitis optica (NMO) is an inflammatory demyelinating central nervous system disease, with recurrent attacks of severe bilateral optic neuritis and longitudinally extensive transverse myelitis. Aggressive immunosuppression is essential to prevent clinical relapses and permanent dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Jade, Jui Dilip, Bansi, Srishti, Singhal, Bhim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586117/
https://www.ncbi.nlm.nih.gov/pubmed/28904454
http://dx.doi.org/10.4103/aian.AIAN_499_16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586117/
https://www.ncbi.nlm.nih.gov/pubmed/28904454
http://dx.doi.org/10.4103/aian.AIAN_499_16

Ejemplares similares